312
Participants
Start Date
May 25, 2022
Primary Completion Date
April 6, 2027
Study Completion Date
October 6, 2027
YL201
Patients will be treated with YL201 intravenous (IV) infusion once every 3 weeks (Q3W) as a cycle.
YL201
Patients will be treated with YL201 intravenous (IV) (A mg/kg or B g/kg infusion once every 3 weeks (Q3W) as a cycle.
YL201 and atezolizumab
Patients will be treated with YL201 intravenous (IV) infusion (A mg/kg or B mg/kg, up to 200mg) followed by atezolizumab on day 1 of each 21 day cycle
RECRUITING
010, New York
RECRUITING
028, Marseille
RECRUITING
004, Washington D.C.
RECRUITING
027, Dijon
RECRUITING
017, Fairfax
RECRUITING
011, Chapel Hill
RECRUITING
037, Madrid
RECRUITING
038, Moncloa-Aravaca
RECRUITING
042, Usera
RECRUITING
036, Madrid
RECRUITING
041, Pozuelo de Alarcón
NOT_YET_RECRUITING
039, Leganés
RECRUITING
040, Pamplona
RECRUITING
026, Bordeaux
RECRUITING
012, Nashville
NOT_YET_RECRUITING
029, Nantes
NOT_YET_RECRUITING
032, Saint-Herblain
RECRUITING
043, Valencia
RECRUITING
006, Ann Arbor
RECRUITING
007, Detroit
RECRUITING
008, St Louis
RECRUITING
015, Irving
NOT_YET_RECRUITING
030, Paris
RECRUITING
016, Tyler
RECRUITING
014, Houston
RECRUITING
013, San Antonio
RECRUITING
003, Lone Tree
RECRUITING
031, Poitiers
RECRUITING
033, Suresnes
RECRUITING
002, Fair Oaks
RECRUITING
019, Tacoma
RECRUITING
018, Spokane
NOT_YET_RECRUITING
025, Zhengzhou
NOT_YET_RECRUITING
024, Guangzhou
RECRUITING
001, La Jolla
RECRUITING
005, Boston
RECRUITING
009, Santa Fe
RECRUITING
020, Edmonton
RECRUITING
021, Kelowna
RECRUITING
022, Brampton
RECRUITING
023, Toronto
RECRUITING
044, Otwock
NOT_YET_RECRUITING
045, Poznan
RECRUITING
034, Barcelona
RECRUITING
035, Barcelona
MediLink Therapeutics (Suzhou) Co., Ltd.
INDUSTRY